Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Heiner van Randenborgh"'
Autor:
Stefan Schöler, Raymonde Busch, R. Paul, Heiner van Randenborgh, Rudolf Hartung, Roland M. Schmid, Michael Alschibaja
Publikováno v:
Urology. 67:137-141
Objectives Blood transfusion in patients with malignant neoplasms may alter the disease outcome because of a theoretical immunomodulatory effect. This effect may reduce prostate-specific antigen (PSA)-free and disease-specific survival in patients wi
Autor:
S. Schöler, Heiner van Randenborgh, Michael Alschibaja, Hubert Kübler, Rudolf Hartung, Raymonde Busch, Roger Paul
Publikováno v:
Urologia Internationalis. 74:203-208
Objective: New prostatic biopsy protocols suggest to increase the core numbers to enhance detection. Additional cores are usually sampled from the lateral part of the p-zone. We direct the sextant biopsy to the most lateral part of the p-zone, theref
Autor:
Antonie Lehmer, Heiner van Randenborgh, Carolus Battistel, Rudolf Hartung, Hubert Kübler, Uwe Treiber, Sebastian Wutzler, Stefan Wagenpfeil, R. Paul
Publikováno v:
The Prostate. 63:385-394
BACKGROUND The platelet-derived growth factor receptor (PDFG-r), a tyrosine kinase, is expressed in 88% of primary prostate cancer and in 80% of the metastases. The tyrosine kinase inhibitor imatinib blocks the PDGF signaling pathway by inhibiting PD
Publikováno v:
Aktuelle Urologie. 32:165-172
Autor:
Heiner van Randenborgh, Christian Plank, Tibor Schuster, Hubert Kübler, Falko Fend, Tania Kummer, Bernd Gansbacher, Heike Pohla, Jürgen Breul, Alexander Buchner, Dolores J. Schendel, Bernd Eisele, Roger Paul, T. Brill, Rudolf Hartung
Publikováno v:
Human gene therapy. 20(12)
Immunotherapy with whole cell cancer vaccines has been tested in various tumor types. This study investigated the safety profile and antitumor activity of an allogeneic prostate carcinoma cell line, LNCaP, expressing recombinant human interleukin-2 a
Autor:
Maria, Picchio, Uwe, Treiber, Ambros J, Beer, Stefan, Metz, Patrick, Bössner, Heiner, van Randenborgh, Roger, Paul, Gregor, Weirich, Michael, Souvatzoglou, Rudolf, Hartung, Markus, Schwaiger, Morand, Piert
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 47(6)
Lymph node involvement is a major prognostic factor in bladder cancer, but the accuracy of conventional imaging modalities for the prediction of regional and distant metastatic diseases is limited. This study was performed to compare the diagnostic a
Autor:
Hubert R, Kübler, Heiner, van Randenborgh, Uwe, Treiber, Sebastian, Wutzler, Carolus, Battistel, Antonie, Lehmer, Stefan, Wagenpfeil, Rudolf, Hartung, Roger, Paul
Publikováno v:
The Prostate. 63(4)
The platelet-derived growth factor receptor (PDFG-r), a tyrosine kinase, is expressed in 88% of primary prostate cancer and in 80% of the metastases. The tyrosine kinase inhibitor imatinib blocks the PDGF signaling pathway by inhibiting PDGF-r autoph
Publikováno v:
Cytokine. 25(4)
Introduction Transfersomes (TF) are new, ultradeformable carriers with characteristics that enable them to penetrate the skin spontaneously. TFs are able to transport noninvasively both low- and high-molecular-weight molecules into the body. Material
Autor:
R. Paul, Heiner van Randenborgh, Rudolf Hartung, Mathias Hoppmann, Markus Günther, Hubert Kübler, Michael Alschibaja
Publikováno v:
European urology. 46(3)
Objective: Biochemical failure after radical prostatectomy (RP) for localized prostate cancer (PC) is the first evidence of disease recurrence. If residual benign prostatic glands are left behind on RP a theoretical PSA production from benign glands
Autor:
Roger, Paul, Stefan, Schöler, Heiner, van Randenborgh, Hubert, Kübler, Michael, Alschibaja, Raymonde, Busch, Rudolf, Hartung
Publikováno v:
Urologia internationalis. 74(3)
New prostatic biopsy protocols suggest to increase the core numbers to enhance detection. Additional cores are usually sampled from the lateral part of the p-zone. We direct the sextant biopsy to the most lateral part of the p-zone, therefore we inve